PMC:7309518 / 2227-2664 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T36","span":{"begin":28,"end":36},"obj":"Disease"},{"id":"T37","span":{"begin":58,"end":61},"obj":"Disease"},{"id":"T38","span":{"begin":83,"end":104},"obj":"Disease"},{"id":"T39","span":{"begin":182,"end":190},"obj":"Disease"},{"id":"T40","span":{"begin":191,"end":200},"obj":"Disease"},{"id":"T41","span":{"begin":342,"end":363},"obj":"Disease"},{"id":"T42","span":{"begin":427,"end":436},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"mondo_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A37","pred":"mondo_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/MONDO_0016218"},{"id":"A38","pred":"mondo_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A39","pred":"mondo_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A40","pred":"mondo_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A41","pred":"mondo_id","subj":"T41","obj":"http://purl.obolibrary.org/obo/MONDO_0005071"},{"id":"A42","pred":"mondo_id","subj":"T42","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Emerging data indicate that COVID-19 can trigger not only GBS but other autoimmune neurological diseases necessitating vigilance for early diagnosis and therapy initiation. Although COVID-19 infection, like most other viruses, can potentially worsen patients with pre-existing autoimmunity, there is no evidence that patients with autoimmune neurological diseases stable on common immunotherapies are facing increased risks of infection."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T10","span":{"begin":218,"end":225},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T11","span":{"begin":397,"end":407},"obj":"http://purl.obolibrary.org/obo/UBERON_0001456"}],"text":"Emerging data indicate that COVID-19 can trigger not only GBS but other autoimmune neurological diseases necessitating vigilance for early diagnosis and therapy initiation. Although COVID-19 infection, like most other viruses, can potentially worsen patients with pre-existing autoimmunity, there is no evidence that patients with autoimmune neurological diseases stable on common immunotherapies are facing increased risks of infection."}

{"project":"LitCovid-PubTator","denotations":[{"id":"86","span":{"begin":250,"end":258},"obj":"Species"},{"id":"87","span":{"begin":317,"end":325},"obj":"Species"},{"id":"88","span":{"begin":28,"end":36},"obj":"Disease"},{"id":"89","span":{"begin":72,"end":104},"obj":"Disease"},{"id":"90","span":{"begin":182,"end":190},"obj":"Disease"},{"id":"91","span":{"begin":191,"end":200},"obj":"Disease"},{"id":"92","span":{"begin":331,"end":363},"obj":"Disease"},{"id":"93","span":{"begin":427,"end":436},"obj":"Disease"}],"attributes":[{"id":"A86","pred":"tao:has_database_id","subj":"86","obj":"Tax:9606"},{"id":"A87","pred":"tao:has_database_id","subj":"87","obj":"Tax:9606"},{"id":"A88","pred":"tao:has_database_id","subj":"88","obj":"MESH:C000657245"},{"id":"A89","pred":"tao:has_database_id","subj":"89","obj":"MESH:D020274"},{"id":"A90","pred":"tao:has_database_id","subj":"90","obj":"MESH:C000657245"},{"id":"A91","pred":"tao:has_database_id","subj":"91","obj":"MESH:D007239"},{"id":"A92","pred":"tao:has_database_id","subj":"92","obj":"MESH:D020274"},{"id":"A93","pred":"tao:has_database_id","subj":"93","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Emerging data indicate that COVID-19 can trigger not only GBS but other autoimmune neurological diseases necessitating vigilance for early diagnosis and therapy initiation. Although COVID-19 infection, like most other viruses, can potentially worsen patients with pre-existing autoimmunity, there is no evidence that patients with autoimmune neurological diseases stable on common immunotherapies are facing increased risks of infection."}

{"project":"LitCovid-sentences","denotations":[{"id":"T18","span":{"begin":0,"end":172},"obj":"Sentence"},{"id":"T19","span":{"begin":173,"end":437},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Emerging data indicate that COVID-19 can trigger not only GBS but other autoimmune neurological diseases necessitating vigilance for early diagnosis and therapy initiation. Although COVID-19 infection, like most other viruses, can potentially worsen patients with pre-existing autoimmunity, there is no evidence that patients with autoimmune neurological diseases stable on common immunotherapies are facing increased risks of infection."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T18","span":{"begin":277,"end":289},"obj":"Phenotype"}],"attributes":[{"id":"A18","pred":"hp_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/HP_0002960"}],"text":"Emerging data indicate that COVID-19 can trigger not only GBS but other autoimmune neurological diseases necessitating vigilance for early diagnosis and therapy initiation. Although COVID-19 infection, like most other viruses, can potentially worsen patients with pre-existing autoimmunity, there is no evidence that patients with autoimmune neurological diseases stable on common immunotherapies are facing increased risks of infection."}